Transscleral drug delivery device and related methods

• US 20060167435A1
• Filed: 02/17/2004
• Published: 07/27/2006
• Est. Priority Date: 02/18/2003
• Status: Abandoned Application

• Current Assignee: Charles Stark Draper Laboratory Incorporated, Massachusetts Eye And Ear Infirmary (Foundation of The Massachusetts Eye and EAR Infirmary Incorporated)
• Original Assignee: Massachusetts Eye And Ear Infirmary (Foundation of The Massachusetts Eye and EAR Infirmary Incorporated)
• Inventors: Borenstein, Jeffrey T., Mescher, Mark J., Miller, Joan W., Gragoudas, Evangelos S., Adamis, Anthony P.
• Application Number:
  US10/545,726
• Publication Number:
  US 20060167435A1
• Time in Patent Office: Days
• US Class Current: 604/500
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61P 27/02 Ophthalmic agents

Abstract

The invention provides a low-profile, dome-shaped body for attachment to a scleral surface of an eye and defining an internal cavity for receiving a drug or other pharmaceutically active agent. The device has an opening for controllably delivering the drug into the eye at therapeutically effective concentrations over a prolonged period of time. When attached, the device does not affect or otherwise restrict movement of the eye. Features of the invention include an optional drug inlet port and puncture guard, both designed for refilling the device while preventing a needle inserted through the inlet port from contacting the sclera.

Claims

1. A transscleral drug delivery device for delivering a drug into a mammalian eye, the device comprising:

(a) a dome member having a base region, the dome member defining a cavity for receiving the drug, and

(b) a base plate attached to the base region, the base plate having a sclera-contacting surface for attaching the device to a scleral surface of the eye, the base plate defining at least one drug outlet port to provide fluid flow communication between the cavity and the scleral surface of the eye when the device is attached to the eye, the drug outlet port comprising at least 25% of the footprint of the base region.

2. The device of claim 1, wherein the base plate has a first diameter and defines at least one drug outlet port having a second diameter, and wherein the second diameter is at least one half of the first diameter.

3. The device of claim 1, wherein the dome member further defines a drug inlet port for introducing the drug into the cavity.

4. The device of claim 3, wherein at least a portion of the dome member is substantially impenetrable to a needle inserted through the drug inlet port.

5. The device of claim 3, wherein at least a portion of the base plate is substantially impenetrable to a needle inserted through the drug inlet port.

6. The device of claim 3 further comprising a puncture guard for preventing a needle inserted through the drug inlet port from contacting the scleral surface of the eye.

7. The device of claim 6, wherein the puncture guard is disposed adjacent to at least one surface of the base plate.

8. The device of claim 6, wherein the puncture guard is disposed adjacent to at least one surface of the dome member.

9. The device of claim 6, wherein the puncture guard is fabricated from a rigid material

10. The device of claim 9, wherein the rigid material comprises a metal.

11. The device of claim 1, wherein the base plate is integral with the dome member.

12. The device of claim 1, wherein at least one of the dome member and the base plate is fabricated from a biocompatible, non-biodegradable material.

13. The device of claim 12, wherein the biocompatible, non-biodegradable material is a metal.

14. The device of claim 1, further comprising a drug disposed within the cavity.

30. A method of delivering a drug into a mammalian eye, the method comprising:

(a) attaching the drug delivery device of claim 1 to a scleral surface of the eye; and

(b) permitting drug disposed within the dome member to exit the cavity and contact the scleral surface.

31. The method of claim 30 further comprising the step of prior to or after step (a) introducing drug into the cavity.

15. A transscleral drug delivery device for delivering a drug into a mammalian eye, the device comprising:

(a) a dome member having a base region, the dome member defining a cavity for receiving the drug and at least one drug inlet port for introducing the drug into the cavity;

(b) a base plate attached to the base region, the base plate having a sclera-contacting surface for attaching the device to a scleral surface of the eye and defining a drug outlet port to provide fluid communication between the cavity and the scleral surface of the eye when the device is attached to the scleral surface; and

(c) a puncture guard for preventing a needle inserted through the drug inlet port from contacting the scleral surface.

16. The device of claim 15, wherein the puncture guard is attached to at least one surface of the base plate.

17. The device of claim 15, wherein the puncture guard is attached to at least one surface of the dome member.

18. The device of claim 15, wherein the puncture guard is fabricated from a rigid material.

19. The device of claim 18, wherein the rigid material comprises a metal.

20. The device of claim 18, wherein the base plate is integral with the dome member.

21. The device of claim 18, wherein at least one of the dome member and the base plate is fabricated from a biocompatible, non-biodegradable material.

22. The device of claim 21, wherein the biocompatible, non-biodegradable material is a metal.

23. The device of claim 15, further comprising a drug disposed within the cavity.

24. A transscleral drug delivery device for delivering a drug into a mammalian eye, the device comprising:

(a) a dome member having a base region, the dome member defining a cavity for receiving the drug and at least one drug inlet port for introducing the drug into the cavity, the drug inlet port configured to prevent a needle inserted therethrough from contacting a scleral surface of the eye when the device is attached to the eye; and

(b) a base plate attached to the base region, the base plate having a sclera-contacting surface for attaching the device to the scleral surface and defining a drug outlet port to provide fluid flow communication between the cavity and the scleral surface when the device is attached to the eye

25. The device of claim 24, wherein the drug inlet port comprises an aperture defined by the dome member and having an axis orthogonal to the aperture, the axis not intersecting the base plate.

26. The device of claim 25, wherein the axis is substantially parallel to the base plate.

27. The device of claim 24, wherein the drug inlet port comprises a generally tubular member defining a lumen having a central longitudinal axis and disposed in an aperture defined by the dome member, the central longitudinal axis of the lumen not intersecting the base plate.

28. The device of claim 27, wherein the central longitudinal axis of the lumen is substantially parallel to the base plate.

29. The device of claim 24, further comprising a drug disposed within the cavity.